Ami Fadia
Stock Analyst at Needham
(4.97)
# 86
Out of 4,531 analysts
612
Total ratings
60%
Success rate
35.4%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Maintained: Buy | $45 | $33.77 | +33.25% | 52 | Jul 16, 2026 | |
| ATAI AtaiBeckley | Downgraded: Hold | n/a | $7.22 | - | 10 | Jul 16, 2026 | |
| BIIB Biogen | Maintained: Buy | $256 | $205.99 | +24.28% | 69 | Jul 14, 2026 | |
| ALKS Alkermes | Maintained: Buy | $61 → $62 | $52.72 | +17.60% | 17 | Jul 13, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $45 | $37.87 | +18.83% | 7 | Jul 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $255 | $247.53 | +3.02% | 69 | Jun 29, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $183 → $235 | $186.16 | +26.24% | 33 | Jun 29, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $537 → $575 | $314.41 | +82.88% | 25 | Jun 29, 2026 | |
| DFTX Definium Therapeutics | Rated: Buy | $38 → $50 | $44.29 | +12.89% | 9 | Jun 23, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $8 → $5 | $1.61 | +210.56% | 19 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.64 | +137.07% | 31 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.21 | +256.29% | 43 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $28.71 | +11.46% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $170.88 | +17.04% | 43 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $25.60 | +48.44% | 37 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $267 | $230.00 | +16.09% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $39.08 | - | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | €75.60 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.15 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $8.80 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $5.20 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.29 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $10.72 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $17.85 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $13.94 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $25.61 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $0.00001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $24 | $0.4707 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $1.5 | $0.027 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $9 | $19.07 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $32.03 | n/a | 11 | Aug 6, 2020 |
Harmony Biosciences Holdings
Jul 16, 2026
Maintained: Buy
Price Target: $45
Current: $33.77
Upside: +33.25%
AtaiBeckley
Jul 16, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.22
Upside: -
Biogen
Jul 14, 2026
Maintained: Buy
Price Target: $256
Current: $205.99
Upside: +24.28%
Alkermes
Jul 13, 2026
Maintained: Buy
Price Target: $61 → $62
Current: $52.72
Upside: +17.60%
MapLight Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $45
Current: $37.87
Upside: +18.83%
Jazz Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $255
Current: $247.53
Upside: +3.02%
Revolution Medicines
Jun 29, 2026
Rated: Buy
Price Target: $183 → $235
Current: $186.16
Upside: +26.24%
Praxis Precision Medicines
Jun 29, 2026
Rated: Buy
Price Target: $537 → $575
Current: $314.41
Upside: +82.88%
Definium Therapeutics
Jun 23, 2026
Rated: Buy
Price Target: $38 → $50
Current: $44.29
Upside: +12.89%
Neumora Therapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $8 → $5
Current: $1.61
Upside: +210.56%
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $4.64
Upside: +137.07%
May 22, 2026
Maintained: Buy
Price Target: $15
Current: $4.21
Upside: +256.29%
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $28.71
Upside: +11.46%
May 11, 2026
Reiterated: Buy
Price Target: $200
Current: $170.88
Upside: +17.04%
May 7, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $25.60
Upside: +48.44%
May 6, 2026
Reiterated: Buy
Price Target: $225 → $267
Current: $230.00
Upside: +16.09%
May 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $39.08
Upside: -
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: €75.60
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $12.15
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $8.80
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $5.20
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $17.29
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $10.72
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $17.85
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $13.94
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $25.61
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Dec 30, 2020
Maintained: Buy
Price Target: $10 → $7
Current: $0.00001
Upside: n/a
Dec 2, 2020
Maintained: Buy
Price Target: $19 → $24
Current: $0.4707
Upside: n/a
Oct 1, 2020
Maintained: Hold
Price Target: $1 → $1.5
Current: $0.027
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $8 → $9
Current: $19.07
Upside: n/a
Aug 6, 2020
Maintained: Hold
Price Target: $12 → $14
Current: $32.03
Upside: n/a